Pancreatic ductal adenocarcinomas in long-term follow-up patients with branch duct intraductal papillary mucinous neoplasms

Pancreas

Volumn 39, Issue 1, 2010, Pages 36-40

  Tanno, Satoshi ^a   Nakano, Yasuhiro ^a   Koizumi, Kazuya ^a   Sugiyama, Yoshiaki ^a   Nakamura, Kazumasa ^a   Sasajima, Junpei ^a   Nishikawa, Tomoya ^a   Mizukami, Yusuke ^a   Yanagawa, Nobuyuki ^a   Fujii, Tsuneshi ^a   Okumura, Toshikatsu ^a   Obara, Takeshi ^a   Kohgo, Yutaka ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Branch duct; Follow up; IPMN; Pancreatic cancer; Risk factor

Indexed keywords

GEMCITABINE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER RISK; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PANCREATOGRAPHY; PRIORITY JOURNAL; VITAL STATISTICS;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; CHOLANGIOPANCREATOGRAPHY, MAGNETIC RESONANCE; DISEASE PROGRESSION; ENDOSONOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROGNOSIS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 74049086515     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181b91cd0     Document Type: Article

References (41)

1. Ohhashi K, Murakami Y, Maruyama M, et al. Four cases of mucous-secreting pancreatic cancer. Prog Dig Endosc. 1982;20: 348-351.
2. Fernandez-del Castillo C, Targarona J, Thayer SP, et al. Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients. Arch Surg. 2003;138:427-433; discussion 433-434.
3. Loftus EV Jr, Olivares-Pakzad BA, Batts KP, et al. Intraductal papillary-mucinous tumors of the pancreas: clinicopathologic features, outcome, and nomenclature. Members of the Pancreas Clinic, and Pancreatic Surgeons of Mayo Clinic. Gastroenterology. 1996;110: 1909-1918.
4. Rivera JA, Fernandez-del Castillo C, Pins M, et al. Pancreatic mucinous ductal ectasia and intraductal papillary neoplasms. A single malignant clinicopathologic entity. Ann Surg. 1997;225:637-644.
5. Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity. Ann Surg. 2001;234:313-321.
6. Tanaka M, Kobayashi K, Mizumoto K, et al. Clinical aspects of intraductal papillary mucinous neoplasm of the pancreas. J Gastroenterol. 2005;40:669-675.
7. Traverso LW, Peralta EA, Ryan JA Jr, et al. Intraductal neoplasms of the pancreas. Am J Surg. 1998;175:426-432.
8. Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg. 2004;239:788-797; discussion 797-799.
9. Conlon KC. Intraductal papillary mucinous tumors of the pancreas. J Clin Oncol. 2005;23:4518-4523.
10. Sugiyama M, Izumisato Y, Abe N, et al. Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas. Br J Surg. 2003;90:1244-1249.
11. Salvia R, Crippa S, Falconi M, et al. Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate? Gut. 2007;56:1086-1090.
12. Schmidt CM, White PB, Waters JA, et al. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg. 2007;246:644-651; discussion 651-654.
13. Bernard P, Scoazec JY, Joubert M, et al. Intraductal papillary-mucinous tumors of the pancreas: predictive criteria of malignancy according to pathological examination of 53 cases. Arch Surg. 2002;137:1274-1278.
14. Rodriguez JR, Salvia R, Crippa S, et al. Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology. 2007;133:72-79; quiz 309-310.
15. Salvia R, Fernandez-del Castillo C, Bassi C, et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg. 2004;239:678-685; discussion 685-687.
16. Matsumoto T, Aramaki M, Yada K, et al. Optimal management of the branch duct type intraductal papillary mucinous neoplasms of the pancreas. J Clin Gastroenterol. 2003;36:261-265.
17. Belyaev O, Seelig MH, Muller CA, et al. Intraductal papillary mucinous neoplasms of the pancreas. J Clin Gastroenterol. 2008;42:284-294.
18. Carter DC. Cancer of the pancreas. Gut. 1990;31:494-496.
19. Tanno S, Nakano Y, Osanai M, et al. A phase I study of oral uracil-tegafur prior to weekly intravenous gemcitabine in patients with advanced pancreatic cancer. Chemotherapy. 2006;52:98-102.
20. Tada M, Kawabe T, Arizumi M, et al. Pancreatic cancer in patients with pancreatic cystic lesions: a prospective study in 197 patients. Clin Gastroenterol Hepatol. 2006;4:1265-1270.
21. Yamaguchi K, Ohuchida J, Ohtsuka T, et al. Intraductal papillary-mucinous tumor of the pancreas concomitant with ductal carcinoma of the pancreas. Pancreatology. 2002;2:484-490.
22. Adsay NV. The "new kid on the block": intraductal papillary mucinous neoplasms of the pancreas: current concepts and controversies. Surgery. 2003;133:459-463.
23. Komori T, Ishikawa O, Ohigashi H, et al. Invasive ductal adenocarcinoma of the remnant pancreatic body 9 years after resection of an intraductal papillary-mucinous carcinoma of the pancreatic head: a case report and comparison of DNA sequence in K-ras gene mutation. Jpn J Clin Oncol. 2002;32:146-151.
24. Shyr YM, Su CH, Tsay SH, et al. Mucin-producing neoplasms of the pancreas. Intraductal papillary and mucinous cystic neoplasms. Ann Surg. 1996;223:141-146.
25. Obara T, Maguchi H, Saitoh Y, et al. Mucin-producing tumor of the pancreas: natural history and serial pancreatogram changes. Am J Gastroenterol. 1993;88:564-569.
26. Tanno S, Nakano Y, Nishikawa T, et al. Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results. Gut. 2008;57:339-343.
27. Talamini G, Bassi C, Falconi M, et al. Alcohol and smoking as risk factors in chronic pancreatitis and pancreatic cancer. Dig Dis Sci. 1999;44:1303-1311.
28. Terris B, Ponsot P, Paye F, et al. Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol. 2000;24:1372-1377.
29. Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17-32.
30. Uehara H, Nakaizumi A, Ishikawa O, et al. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas. Gut. 2008;57:1561-1565.
31. Izawa T, Obara T, Tanno S, et al. Clonality and field cancerization in intraductal papillary-mucinous tumors of the pancreas. Cancer. 2001;92:1807-1817.
32. Z'Graggen K, Rivera JA, Compton CC, et al. Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas. Ann Surg. 1997;226: 491-498; discussion 498-500.
33. Biankin AV, Kench JG, Biankin SA, et al. Pancreatic intraepithelial neoplasia in association with intraductal papillary mucinous neoplasms of the pancreas: implications for disease progression and recurrence. Am J Surg Pathol. 2004;28:1184-1192.
34. Hruban RH, Takaori K, Klimstra DS, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol. 2004;28:977-987.
35. Hruban RH, Takaori K, Canto M, et al. Clinical importance of precursor lesions in the pancreas. J Hepatobiliary Pancreat Surg. 2007;14: 255-263.
36. Obara T, Saitoh Y, Maguchi H, et al. Multicentric development of pancreatic intraductal carcinoma through atypical papillary hyperplasia. Hum Pathol. 1992;23:82-85.
37. Inagaki M, Maguchi M, Kino S, et al. Mucin-producing tumors of the pancreas: clinicopathological features, surgical treatment, and outcome. J Hepatobiliary Pancreat Surg. 1999;6:281-285.
38. Fujii T, Obara T, Maguchi H, et al. Clinicopathologic study of multiple mucin-producing tumors of the pancreas: multicentric development of carcinoma through atypical hyperplasia. J Jpn Pancreat Soc. 1996;11:344-352.
39. Bendix Holme J, Jacobsen N, Rokkjaer M, et al. Total pancreatectomy in six patients with intraductal papillary mucinous tumour of the pancreas: the treatment of choice. HPB (Oxford). 2001;3:257-262.
40. Hingorani SR, Petricoin EF, Maitra A, et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell. 2003;4:437-450.
41. Siveke JT, Einwachter H, Sipos B, et al. Concomitant pancreatic activation of Kras(G12D) and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN. Cancer Cell. 2007;12:266-279.